Stocktoria
Chemomab Therapeutics Ltd. CMMB
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2012-08-14
Chemomab Therapeutics Ltd. statistics & valuation
Market cap$11.4M
P / B0.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -65.1% | -82.2% | -109.3% | -64.2% | -19.4% |
| Return on equity | -72.9% | -103.0% | -142.5% | -76.3% | -20.3% |
| Current ratio | 9.08 | 4.98 | 4.32 | 6.18 | 23.66 |
Source: SEC EDGAR filings · CIK 0001534248 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.